Diagnostic performance of DNA probe-based and PCR-based molecular vaginitis testing.

Using retrospective data from U.S. Food and Drug Administration-approved/cleared molecular vaginal panels, molecular methods were found to have higher detection for vaginitis and lower detection for bacterial vaginitis when compared to probe-based methods. In addition, the differentiation of and non- yeast has not reached the physician community as we observed noncompliance in recommended therapy. Furthermore, the pros and cons of migrating to molecular testing from conventional microscopy for identifying bacterial vaginitis and fungal vaginitis have been examined and reported in this paper. Interestingly, the mean (SD) age for patients with was 40.5 (40.0-41.1) years. Patients with were 5.2-8.1 (mean 6.7) years older than patients with .